《全日速報》恆指全日收報19,415點 升109點; 恆生科技指數全日收報4,074點 升20點 商湯-W跌逾8% 網易、匯控創新高
恆指全日收19,415點,升109點或0.6%。恆生科技指數報4,074點,升20點或0.5%。國指升22點或0.3%,報6,613點。大市成交額760.46億元。
活躍重磅股表現:
美團(03690.HK) 收127.6元,上升0.9%;
友邦(01299.HK) 收81.55元,上升0.7%;
建行(00939.HK) 收5.09元,下跌0.6%;
阿里巴巴(09988.HK) 收84元,上升0.5%;
騰訊(00700.HK) 收339.2元,上升0.4%;
異動恆指及國指成份股:
商湯-W(00020.HK) 收1.99元,下跌8.7%;
翰森製藥(03692.HK) 收13.82元,上升6.6%;
小鵬汽車(09868.HK) 收54.45元,下跌6.5%;
東方海外(00316.HK) 收115.4元,上升3.9%;
京東健康(06618.HK) 收52.45元,上升3.9%;
中生製藥(01177.HK) 收3.58元,上升3.5%;
藥明生物(02269.HK) 收39.4元,上升3.4%;
網易(09999.HK) 收157.4元,上升1.5%,創新高;
匯控(00005.HK) 收62.25元,上升0.5%,創新高;
異動綜合中小型股:
華寶國際(00336.HK) 收3.6元,上升24.1%;
榮昌生物(09995.HK) 收40.35元,上升18.2%;
東方甄選(01797.HK) 收30.7元,上升15.4%;
雲頂新耀-B(01952.HK) 收20.65元,下跌13.6%;
科濟藥業-B(02171.HK) 收10.76元,上升11.3%;
康方生物(09926.HK) 收40.15元,上升10.9%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.